Feb 26, 2026 4:05 pm EST KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Jan 29, 2026 4:05 pm EST KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
